Gastric cancer drug trials - are women second class citizens?

Nat Rev Clin Oncol. 2014 Jul;11(7). doi: 10.1038/nrclinonc.2013.231-c1. Epub 2014 Jun 3.

Authors

Lishi Wang¹, Yan Jiao¹, Yun Jiao², Yanhong Cao³, Weikuan Gu¹

Affiliations

¹ Department of Orthopaedic Surgery, Campbell Clinic and Pathology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
² Department of Neuroscience, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
³ Center for Endemic Disease Control, Centers for Disease Control and Prevention, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.

PMID: 24889767
DOI: 10.1038/nrclinonc.2013.231-c1

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma / drug therapy*
Antibodies, Monoclonal / administration & dosage*
Esophageal Neoplasms / drug therapy*
Female
Humans
Male
Molecular Targeted Therapy / methods*
Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors*

Substances

Antibodies, Monoclonal
Vascular Endothelial Growth Factor Receptor-2